Skip to main content

ORIGINAL RESEARCH article

Front. Cell. Infect. Microbiol.
Sec. Intestinal Microbiome
Volume 14 - 2024 | doi: 10.3389/fcimb.2024.1495364
This article is part of the Research Topic The microbiome in the development of gastrointestinal diseases View all 14 articles

Intestinal microbiome changes and mechanisms of maintenance haemodialysis patients with constipation

Provisionally accepted
Aiping Zhang Aiping Zhang 1Shilei Chen Shilei Chen 2Yanqin Zhu Yanqin Zhu 1Xin Zhou Xin Zhou 1Mengqi Wu Mengqi Wu 1Bin Lu Bin Lu 1Yan Zhu Yan Zhu 1Xinyu Xu Xinyu Xu 1Riyang Lin Riyang Lin 1*
  • 1 Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, China
  • 2 Hangzhou Xihu District Zhuantang Street Community Health Service Centre, Hangzhou, China

The final, formatted version of the article will be published soon.

    Abstract: Background Constipation is a common symptom in maintenance haemodialysis patients and greatly affects the quality of survival of haemodialysis patients. Fecal microbiota transplantation and probiotics are feasible treatments for functional constipation, but there is still a gap in the research on the characteristics of gut flora in patients with maintenance haemodialysis combined with constipation. The aim of this study is to clarify the characteristics of the intestinal flora and its changes in maintenance haemodialysis patients with constipation. Methods Fecal samples were collected from 45 participants, containing 15 in the maintenance haemodialysis constipation group,15 in the maintenance haemodialysis non-constipation group and 15 in the healthy control group. These samples were analyzed using 16S rRNA gene sequencing. The feature of the intestinal microbiome of maintenance haemodialysis constipation group and the microbiome differences among the three groups were elucidated by species annotation analysis, α-diversity analysis, β-diversity analysis, species difference analysis, and predictive functional analysis. Results The alpha diversity analysis indicated that maintenance haemodialysis constipation group was less diverse and homogeneous than maintenance haemodialysis non-constipation group and healthy control group. At the genus level, the top ten dominant genera in maintenance haemodialysis constipation group patients were Enterococcus, Escherichia-Shigella, Bacteroides, Streptococcus, Bifidobacterium, Ruminococcus_gnavus_group, Lachnospiraceae_unclassified, Faecalibacterium, Akkermansia and UCG-002. Compared with non-constipation group, the Enterococcus, Rhizobiales_unclassified, Filomicrobium, Eggerthella, Allobaculum, Prevotella_7, Gordonibacter, Mitochondria_unclassified, Lachnoanaerobaculum were significantly higher in constipation group (p<0.05). Compared with non-constipation group, the Kineothrix, Rhodopirellula, Weissella were significantly lower in constipation group (p<0.05). The predictive functional analysis revealed that compared with non-constipation group, constipation group was significantly enriched in pathways associated with pyruate metabolism, flavonoid biosynthesis. Conclusions This study describes for the first time the intestinal microbiome characteristics of maintenance haemodialysis patients with constipation. The results of this study suggest that there is a difference in the intestinal flora between maintenance haemodialysis patients with constipation and maintenance haemodialysis patients without constipation.

    Keywords: Constipation, gut microbiome, 16S rRNA, Maintenance haemodialysis (MHD), Intestinal biomarker

    Received: 12 Sep 2024; Accepted: 18 Oct 2024.

    Copyright: © 2024 Zhang, Chen, Zhu, Zhou, Wu, Lu, Zhu, Xu and Lin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Riyang Lin, Hangzhou Hospital of Traditional Chinese Medicine, Hangzhou, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.